REFERENCES
1. Shaw KA, Williams S, Patrick ME, et al. Prevalence and early identification of autism spectrum disorder among children aged 4 and 8 years - autism and developmental disabilities monitoring network, 16 sites, United States, 2022. MMWR Surveill Summ. 2025;74:1-22.
2. Gogate A, Kaur K, Khalil R, et al. The genetic landscape of autism spectrum disorder in an ancestrally diverse cohort. NPJ Genom Med. 2024;9:62.
3. Park JC, Im SH. The gut-immune-brain axis in neurodevelopment and neurological disorders. Microbiome Res Rep. 2022;1:23.
4. Hung LY, Margolis KG. Autism spectrum disorders and the gastrointestinal tract: insights into mechanisms and clinical relevance. Nat Rev Gastroenterol Hepatol. 2024;21:142-63.
5. Neuhaus E, Bernier RA, Tham SW, Webb SJ. Gastrointestinal and psychiatric symptoms among children and adolescents with autism spectrum disorder. Front Psychiatry. 2018;9:515.
6. Chakraborty P, Carpenter KLH, Major S, et al. Gastrointestinal problems are associated with increased repetitive behaviors but not social communication difficulties in young children with autism spectrum disorders. Autism. 2021;25:405-15.
7. Nikolov RN, Bearss KE, Lettinga J, et al. Gastrointestinal symptoms in a sample of children with pervasive developmental disorders. J Autism Dev Disord. 2009;39:405-13.
8. Hou K, Wu ZX, Chen XY, et al. Microbiota in health and diseases. Signal Transduct Target Ther. 2022;7:135.
9. Sender R, Fuchs S, Milo R. Revised Estimates for the number of human and bacteria cells in the body. PLoS Biol. 2016;14:e1002533.
10. Osama A, Anwar AM, Ezzeldin S, et al. Integrative multi-omics analysis of autism spectrum disorder reveals unique microbial macromolecules interactions. J Adv Res. 2025;77:265-79.
11. Park JC, Chang L, Kwon HK, Im SH. Beyond the gut: decoding the gut-immune-brain axis in health and disease. Cell Mol Immunol. 2025;22:1287-312.
12. Iglesias-Vázquez L, Van Ginkel Riba G, Arija V, Canals J. Composition of gut microbiota in children with autism spectrum disorder: a systematic review and meta-analysis. Nutrients. 2020;12:792.
13. Li N, Yang J, Zhang J, et al. Correlation of gut microbiome between ASD children and mothers and potential biomarkers for risk assessment. Genom Proteom Bioinf. 2019;17:26-38.
14. Wang L, Christophersen CT, Sorich MJ, Gerber JP, Angley MT, Conlon MA. Low relative abundances of the mucolytic bacterium Akkermansia muciniphila and Bifidobacterium spp. in feces of children with autism. Appl Environ Microbiol. 2011;77:6718-21.
15. Strati F, Cavalieri D, Albanese D, et al. New evidences on the altered gut microbiota in autism spectrum disorders. Microbiome. 2017;5:24.
16. Tomova A, Husarova V, Lakatosova S, et al. Gastrointestinal microbiota in children with autism in Slovakia. Physiol Behav. 2015;138:179-87.
17. Kim HS, Oh SJ, Kim BK, et al. Dysbiotic signatures and diagnostic potential of gut microbial markers for inflammatory bowel disease in Korean population. Sci Rep. 2024;14:23701.
18. Diaz Heijtz R, Wang S, Anuar F, et al. Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci U S A. 2011;108:3047-52.
19. Chu C, Murdock MH, Jing D, et al. The microbiota regulate neuronal function and fear extinction learning. Nature. 2019;574:543-8.
20. Sharon G, Cruz NJ, Kang DW, et al. Human gut microbiota from autism spectrum disorder promote behavioral symptoms in mice. Cell. 2019;177:1600-1618.e17.
21. Zhong J, Zhu B, Zou Z, et al. Gut microbiota mediates the beneficial effects of exercise on autism-like behaviors. BMC Microbiol. 2026;26:157.
22. Park JC, Sim MA, Lee C, et al. Gut microbiota and brain-resident CD4+ T cells shape behavioral outcomes in autism spectrum disorder. Nat Commun. 2025;16:6422.
23. Buffington SA, Dooling SW, Sgritta M, et al. Dissecting the contribution of host genetics and the microbiome in complex behaviors. Cell. 2021;184:1740-1756.e16.
24. Barone R, Alaimo S, Messina M, et al.; MIMIC-Autism Group. A subset of patients with autism spectrum disorders show a distinctive metabolic profile by dried blood spot analyses. Front Psychiatry. 2018;9:636.
25. Orozco JS, Hertz-Picciotto I, Abbeduto L, Slupsky CM. Metabolomics analysis of children with autism, idiopathic-developmental delays, and down syndrome. Transl Psychiatry. 2019;9:243.
26. Lingampelly SS, Naviaux JC, Heuer LS, et al. Metabolic network analysis of pre-ASD newborns and 5-year-old children with autism spectrum disorder. Commun Biol. 2024;7:536.
27. Abdulamir HA, Abdul-Rasheed OF, Abdulghani EA. Serotonin and serotonin transporter levels in autistic children. Saudi Med J. 2018;39:487-94.
28. Kubota M, Yoshihara Y, Uwatoko T, et al. Elevated brain glutamine levels in adults with autism spectrum disorder: a 7T MRS study. Mol Psychiatry. 2026;31:3062-9.
29. Hassan TH, Abdelrahman HM, Abdel Fattah NR, et al. Blood and brain glutamate levels in children with autistic disorder. Res Autism Spect Dis. 2013;7:541-8.
30. Jameson KG, Kazmi SA, Ohara TE, et al. Select microbial metabolites in the small intestinal lumen regulate vagal activity via receptor-mediated signaling. iScience. 2025;28:111699.
31. Mitchell KJ, Dahly DL, Bishop DVM. Conceptual and methodological flaws undermine claims of a link between the gut microbiome and autism. Neuron. 2026;114:196-211.
32. Wang W, Fu P. Gut microbiota analysis and in silico biomarker detection of children with autism spectrum disorder across cohorts. Microorganisms. 2023;11:291.
33. Yap CX, Henders AK, Alvares GA, et al. Autism-related dietary preferences mediate autism-gut microbiome associations. Cell. 2021;184:5916-5931.e17.
34. Mathew NE, Mallitt KA, Masi A, et al. Dietary intake in children on the autism spectrum is altered and linked to differences in autistic traits and sensory processing styles. Autism Res. 2022;15:1824-39.
35. Wu Y, Wong OWH, Chen S, et al. Gut microbiome mediates the causal link between autism spectrum disorder and dietary preferences: a mendelian randomization study. Int J Mol Sci. 2026;27:2006.
36. Zheng D, Liwinski T, Elinav E. Interaction between microbiota and immunity in health and disease. Cell Res. 2020;30:492-506.
37. Park JC, Im SH. Of men in mice: the development and application of a humanized gnotobiotic mouse model for microbiome therapeutics. Exp Mol Med. 2020;52:1383-96.
38. Verma R, Lee C, Jeun EJ, et al. Cell surface polysaccharides of Bifidobacterium bifidum induce the generation of Foxp3+ regulatory T cells. Sci Immunol. 2018;3:eaat6975.
39. Lee C, Kim SW, Verma R, et al. Probiotic consortium confers synergistic anti-inflammatory effects in inflammatory disorders. Nutrients. 2024;16:790.
40. Sharma G, Sharma A, Kim I, et al. A dietary commensal microbe enhances antitumor immunity by activating tumor macrophages to sequester iron. Nat Immunol. 2024;25:790-801.
41. Smith PM, Howitt MR, Panikov N, et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science. 2013;341:569-73.
42. Antunes KH, Fachi JL, de Paula R, et al. Microbiota-derived acetate protects against respiratory syncytial virus infection through a GPR43-type 1 interferon response. Nat Commun. 2019;10:3273.
43. Zhang F, Xu W, Tang Q, Huang J. The identification of metabolites from gut microbiota in autism spectrum disorder via network pharmacology. Sci Rep. 2025;15:31765.
44. Chen M, Su T, Chen Y, et al. Comorbidity of allergic and autoimmune diseases in patients with autism spectrum disorder: a nationwide population-based study. Res Autism Spect Dis. 2013;7:205-12.
45. Enstrom AM, Van de Water JA, Ashwood P. Autoimmunity in autism. Curr Opin Investig Drugs. 2009;10:463-73.
46. Zhao H, Zhang H, Liu S, Luo W, Jiang Y, Gao J. Association of peripheral blood levels of cytokines with autism spectrum disorder: a meta-analysis. Front Psychiatry. 2021;12:670200.
47. Li X, Chauhan A, Sheikh AM, et al. Elevated immune response in the brain of autistic patients. J Neuroimmunol. 2009;207:111-6.
48. Kim S, Kim H, Yim YS, et al. Maternal gut bacteria promote neurodevelopmental abnormalities in mouse offspring. Nature. 2017;549:528-32.
49. Heo Y, Zhang Y, Gao D, Miller VM, Lawrence DA. Aberrant immune responses in a mouse with behavioral disorders. PLoS One. 2011;6:e20912.
50. Di L, Huang P, He Y, Sun N, Chi L, Huang L. Gut dysbiosis is associated with increased blood-brain barrier permeability and cognitive impairment in elderlies with coronary heart disease. Front Aging Neurosci. 2025;17:1640761.
51. Braniste V, Al-Asmakh M, Kowal C, et al. The gut microbiota influences blood-brain barrier permeability in mice. Sci Transl Med. 2014;6:263ra158.
52. Li F, Ke H, Wang S, et al. Leaky gut plays a critical role in the pathophysiology of autism in mice by activating the lipopolysaccharide-mediated toll-like receptor 4-myeloid differentiation factor 88-nuclear factor kappa B signaling pathway. Neurosci Bull. 2023;39:911-28.
53. Filiano AJ, Xu Y, Tustison NJ, et al. Unexpected role of interferon-γ in regulating neuronal connectivity and social behaviour. Nature. 2016;535:425-9.
54. Reed MD, Yim YS, Wimmer RD, et al. IL-17a promotes sociability in mouse models of neurodevelopmental disorders. Nature. 2020;577:249-53.
55. Zipp F, Bittner S, Schafer DP. Cytokines as emerging regulators of central nervous system synapses. Immunity. 2023;56:914-25.
56. Lee B, Kwon JT, Jeong Y, et al. Inflammatory and anti-inflammatory cytokines bidirectionally modulate amygdala circuits regulating anxiety. Cell. 2025;188:2190-2202.e15.
57. Yang L, Andina ML, Witkowski M, et al. IL-1R1-positive dorsal raphe neurons drive self-imposed social withdrawal in sickness. Cell. 2026;189:272-286.e19.
58. Yoshida TM, Nguyen M, Zhang L, et al. The subfornical organ is a nucleus for gut-derived T cells that regulate behaviour. Nature. 2025;643:499-508.
59. White Z, Cabrera I, Mei L, et al. Gut inflammation promotes microbiota-specific CD4 T cell-mediated neuroinflammation. Nature. 2025;643:509-18.
60. Sgritta M, Dooling SW, Buffington SA, et al. Mechanisms underlying microbial-mediated changes in social behavior in mouse models of autism spectrum disorder. Neuron. 2019;101:246-259.e6.
61. Nettleton JE, Klancic T, Schick A, et al. Prebiotic, probiotic, and synbiotic consumption alter behavioral variables and intestinal permeability and microbiota in BTBR mice. Microorganisms. 2021;9:1833.
62. Hsiao EY, McBride SW, Hsien S, et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell. 2013;155:1451-63.
63. Wu WL, Adame MD, Liou CW, et al. Microbiota regulate social behaviour via stress response neurons in the brain. Nature. 2021;595:409-14.
64. Engevik MA, Luck B, Visuthranukul C, et al. Human-derived bifidobacterium dentium modulates the mammalian serotonergic system and gut-brain axis. Cell Mol Gastroenterol Hepatol. 2021;11:221-48.
65. Santocchi E, Guiducci L, Prosperi M, et al. Effects of probiotic supplementation on gastrointestinal, sensory and core symptoms in autism spectrum disorders: a randomized controlled trial. Front Psychiatry. 2020;11:550593.
66. Mazzone L, Dooling SW, Volpe E, et al. Precision microbial intervention improves social behavior but not autism severity: a pilot double-blind randomized placebo-controlled trial. Cell Host Microbe. 2024;32:106-116.e6.
67. Hassib L, Kanashiro A, Pedrazzi JFC, et al. Microbiota-based therapies as novel targets for autism spectrum disorder: a systematic review and meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2025;139:111385.
68. Liu S, Xi H, Xue X, et al. Clostridium butyricum regulates intestinal barrier function via trek1 to improve behavioral abnormalities in mice with autism spectrum disorder. Cell Biosci. 2024;14:95.
69. Alsubaiei SRM, Alfawaz HA, Almubarak AY, Alabdali NA, Ben Bacha A, El-Ansary A. Independent and combined effects of probiotics and prebiotics as supplements or food-rich diets on a propionic-acid-induced rodent model of autism spectrum disorder. Metabolites. 2022;13:50.
